Description
Retatrutide (RETA) 30 MG | For Research Use Only
Retatrutide is an investigational triple-receptor agonist studied for its unique ability to activate GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. This multi-pathway approach has made Retatrutide a significant focus of metabolic and obesity research.
Researchers are exploring Retatrutide for its potential effects on appetite regulation, energy expenditure, glucose metabolism, body composition, and insulin sensitivity. By targeting three distinct metabolic pathways, Retatrutide is being studied as one of the most comprehensive next-generation peptide candidates in weight management and metabolic health research.
For laboratory and research purposes only. Not for human consumption.
